This content is machine translated Rheumatologic overlap syndrome When RA, SSc and SLE strike together Overlap syndromes, which include systemic scleroderma (SSc), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), are rare. When the symptoms of the three autoimmune diseases occur simultaneously, this overlap poses…
View Post 5 min This content is machine translated Rheumatoid arthritis JAK inhibitor reduces pain for a long time Patients with active rheumatoid arthritis often suffer from considerable pain. Therefore, pain control is an important treatment goal in this patient group. In a post-hoc analysis of the FINCH studies…
View Post 8 min This content is machine translated Rheumatoid arthritis News on gender medicine in the RA Rheumatoid arthritis (RA) is the most common inflammatory rheumatic joint disease, affecting women 2-3 times more often than men. The exact interaction of immunological, hormonal and genetic factors has not… CME-Test
View Post 8 min This content is machine translated Rheumatoid arthritis News on gender medicine in the RA Rheumatoid arthritis (RA) is the most common inflammatory rheumatic joint disease, affecting women 2–3 times more often than men. The exact interaction of immunological, hormonal and genetic factors has not… CME-Test
View Post 4 min This content is machine translated Rheumatoid arthritis Building bridges or tearing them down? Bridging therapy with glucocorticoids (GC) as a temporary part of initial treatment for rheumatoid arthritis (RA) helps to rapidly suppress disease activity. However, it is suspected that patients who have…
View Post 5 min This content is machine translated Update EULAR treatment recommendations Carefully consider the use of JAK inhibitors The goal of rheumatoid arthritis (RA) therapy today is clinical remission. The earlier the disease is detected, the better the chances of achieving this goal. For the road ahead, EULAR…
View Post 5 min This content is machine translated Rheumatoid arthritis Halting joint destruction through early use of DMARDs Early adequate therapy of rheumatoid arthritis (RA) is of central importance for the entire further course of the disease, current guidelines conclude. After diagnosis, the indication for disease-modifying therapy should…
View Post 6 min This content is machine translated Rheumatoid arthritis Therapy overview 2017 – and what’s next? Prof. Paul Hasler, MD, Chief of Rheumatology, Kantonsspital Aarau, discussed the new approval of baricitinib in the indication of moderate to severe active RA with HAUSARZT PRAXIS. Where does the…
View Post 4 min This content is machine translated Rheumatoid arthritis in the early stages Countermeasures in the early stages can prevent manifest rheumatoid arthritis It would be a dream: to identify patients in the early stages of rheumatoid arthritis (pre-RA) and to prevent the manifestation of the disease through efficient countermeasures. Is this also…
View Post 3 min This content is machine translated Rapid start of therapy, intensive controls Strong helpers against rheumatoid arthritis At the Update Refresher General Internal Medicine, Michael Andor, MD, Center for Spine Medicine PRODORSO, Zurich, provided information on the current therapy of rheumatoid arthritis (RA). The treatment of RA…
View Post 6 min This content is machine translated Rheumatoid arthritis How can remission be achieved? Once joint damage has occurred in the course of rheumatoid arthritis, it can no longer be reversed with medication. Therefore, it is important to use basic therapeutics as early as…
